Agilent to acquire Biocare Medical in $950 million all-cash deal
09/03/2026 07:05
March 9 (Reuters) - Life sciences firm Agilent Technologies A.N said on Monday that it will acquire clinical pathology firm Biocare Medical in an all-cash deal valued at $950 million. (Reporting by Gursimran Kaur in Bengaluru; Editing by Sherry Jacob-Phillips) ((GursimranKaur.Mehar@thomsonreuters.com;))